Overview

A Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, Tolerability of LPRI-424, 13 Cycles

Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
The main objective of this trial is to demonstrate the contraceptive efficacy of LPRI424, Additional goals of the trial are to demonstrate the safety and tolerability of LPRI424.
Phase:
Phase 3
Details
Lead Sponsor:
Insud Pharma
Collaborator:
Chemo Research
Treatments:
Contraceptive Agents
Contraceptives, Oral
Contraceptives, Oral, Hormonal
Dienogest
Ethinyl Estradiol